blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2393507

EP2393507 - TRIMERIC HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION [Right-click to bookmark this link]
Former [2011/50]TRIMERICH HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION
[2012/07]
StatusThe application is deemed to be withdrawn
Status updated on  29.05.2015
Database last updated on 31.05.2024
Most recent event   Tooltip29.05.2015Application deemed to be withdrawnpublished on 01.07.2015  [2015/27]
Applicant(s)For all designated states
New York Blood Center, Inc.
310 East 67 Street
New York, NY 10065 / US
[2011/50]
Inventor(s)01 / JIANG, Shibo
65-38 Utopia Parkway
Fresh Meadows, NY 11365 / US
02 / QI, Zhi
98-25 Harding H Expy Apt. 10N
Corona, NY 11368 / US
03 / CHEN, Xi
87-01 51st Avenue
Elmhurst, NY 11373 / US
04 / PAN, Chungen
Hanjingxuan Building A Apt. 1005
Hanjing Street
Wushan Road
Tianhe District
Guangzhou Guangdong Province 510630 / CN
 [2012/02]
Former [2011/50]01 / JIANGS, Shibo
65-38 Utopia Parkway
Fresh Meadows, NY 11365 / US
02 / QI, Zhi
98-25 Harding H Expy Apt. 10N
Corona, NY 11368 / US
03 / CHEN, Xi
87-01 51st Avenue
Elmhurst, NY 11373 / US
04 / PAN, Chungen
Hanjingxuan Building A Apt. 1005
Hanjing Street
Wushan Road
Tianhe District
Guangzhou Guangdong Province 510630 / CN
Representative(s)Radkov, Stoyan Atanassov
Urquhart-Dykes & Lord LLP
Euston House
24 Eversholt Street
London NW1 1AD / GB
[N/P]
Former [2013/44]Radkov, Stoyan Atanassov
Urquhart-Dykes & Lord LLP
33 Glasshouse Street
London W1B 5DG / GB
Former [2011/50]Thomas, Simon
Urquhart-Dykes & Lord LLP
3rd Floor
33 Glasshouse Street
London W1B 5DG / GB
Application number, filing date10703782.208.02.2010
WO2010US23522
Priority number, dateUS20090151110P09.02.2009         Original published format: US 151110 P
[2011/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010091373
Date:12.08.2010
Language:EN
[2010/32]
Type: A2 Application without search report 
No.:EP2393507
Date:14.12.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 12.08.2010 takes the place of the publication of the European patent application.
[2011/50]
Search report(s)International search report - published on:EP30.09.2010
ClassificationIPC:A61K38/17, A61P31/18
[2011/50]
CPC:
A61K38/162 (EP,US); A61P31/18 (EP); C07K14/005 (EP,US);
C12N7/00 (US); A61K38/00 (EP,US); C07K2319/735 (EP,US);
C12N2740/16022 (US); C12N2740/16033 (US); C12N2740/16111 (US);
C12N2740/16122 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/50]
TitleGerman:TRIMERE HIV-FUSIONSHEMMER ZUR BEHANDLUNG ODER VORBEUGUNG DER HIV-INFEKTION[2011/50]
English:TRIMERIC HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION[2012/07]
French:INHIBITEURS DE FUSION DU VIH POUR LE TRAITEMENT OU LA PRÉVENTION DE L'INFECTION PAR LE VIH[2011/50]
Former [2011/50]TRIMERICH HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION
Entry into regional phase26.07.2011National basic fee paid 
26.07.2011Designation fee(s) paid 
26.07.2011Examination fee paid 
Examination procedure26.07.2011Amendment by applicant (claims and/or description)
26.07.2011Examination requested  [2011/50]
10.07.2014Despatch of a communication from the examining division (Time limit: M06)
21.01.2015Application deemed to be withdrawn, date of legal effect  [2015/27]
17.02.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/27]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.07.2014
Fees paidRenewal fee
24.02.2012Renewal fee patent year 03
27.02.2013Renewal fee patent year 04
27.02.2014Renewal fee patent year 05
26.02.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]US2004044183  (ECKERT DEBRA M [US], et al) [X] 1,2,8-10 * abstract * [Y] 3-7;
 [XY]US2005106177  (SODROSKI JOSEPH G [US], et al) [X] 1-3,8-10 * abstract * * paragraph [0018] - paragraph [0019] * [Y] 3-7;
 [X]WO2006038131  (EUROPEAN MOLECULAR BIOLOGY LAB EMBL [DE], et al) [X] 1,2,8-10 * abstract *;
 [E]WO2010045613  (NEW YORK BLOOD CT INC [US], et al) [E] 1-4,8-10* sequence 24 *;
 [A]  - LOUIS JOHN M ET AL, "Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M301627200, vol. 278, no. 22, ISSN 0021-9258, (20030530), pages 20278 - 20285, (20030324), XP002481442 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M301627200
 [A]  - LIU SHUWEN ET AL, "HIV entry inhibitors targeting gp41: From polypeptides to small-molecule compounds", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL LNKD- DOI:10.2174/138161207779313722, (20070101), vol. 13, no. 2, ISSN 1381-6128, pages 143 - 162, XP002499294 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.2174/138161207779313722
by applicant   - HENIKOFF; HENIKOFF, PROC. NATL. ACAD SCI. USA, (1992), vol. 89, page 10915
    - NEEDLEMAN; WUNSCH, J. MOL. BIO., (1970), vol. 48, page 443
    - "The use of interspecies scaling in toxicokinetics", MARDENTI, J.; CHAPPELL, W. ET AL., Toxicokinetics and New Drug Development, PERGAMON PRESS, (1989), pages 42 - 96
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.